VERTEX PHARMACEUTICALS earnings per share and revenue

4VRTX earnings per share for the last quarter are -11.98 EUR whereas the estimation was -10.85 EUR which accounts for -10.36% surprise. Company revenue for the same period amounts to 2.47 B EUR despite the estimated figure of 2.49 B EUR. Estimated earnings per share for the next quarter are 3.66 EUR, and revenue is expected to reach 2.41 B EUR. Also watch annual changes over time to get a bigger picture of 4VRTX earnings per share and revenue dynamics.